Corticosteroid treatment of asthma

December 2004
Thorax;Dec2004 Supplement, Vol. 59, p10
Academic Journal
This article presents abstracts of several medical studies conducted to treat asthma with corticosteroids. In one study, 95 individuals with mild asthma were recruited to a multicentre, randomised, double blind, parallel group study comparing inhaled beclomethasone, for 12 weeks in smokers and non-smokers. The primary endpoint was the change in morning peak expiratory flow. It found that smokers compared with non-smokers with mild persistent asthma are resistant to the therapeutic effect of low dose inhaled corticosteroid treatment, administered for a 12 week period.


Related Articles

  • Comparison of inhalant Fluticasone and Beclomethasone in treating mild and moderate persistent asthma in children. Issabeagloo, Eilyad; Aharchi, Taghi; Kermanizadeh, Parviz; Taghizadieh, Mohammad // Annals of Biological Research;2012, Vol. 3 Issue 3, p1536 

    Asthma is one of the most common diseases of childhood ages. Different medications are used in periods between asthma attacks that their principles are inhalant corticosteroids such as beclomethasone and fluticasone using fluticasone alone, can cause diminish in asthma symptoms in children and...

  • Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. Papi, Alberto; Nicolini, Gabriele; Crimi, Nunzio; Fabbri, Leonardo; Olivieri, Dario; Rossi, Andrea; Paggiaro, Pierluigi // Respiratory Research;Jun2012, Vol. 13 Issue 6, p1 

    Background: Asthma guidelines suggest that therapy can be reduced once asthma is controlled. Despite these recommendations, asthmatic patients are seldom stepped down in clinical practice, and questions remain about when and how to reduce asthma therapy. The purpose of the present study was to...

  • Tapering inhaled steroids effective for chronic asthma. See, Sharon; Rubin, Susan // Journal of Family Practice;Oct2003, Vol. 52 Issue 10, p748 

    The article discusses that chronic asthma patients may reduce their dose of inhaled corticosteroids as long as they use at least 1000µg of beclomethasone or its daily equivalent. Patients can reduce their dose for as high as fifty percent without compromising control of symptoms. In a study...

  • COMMENTARY: Symptomatic use of beclomethasone plus albuterol and regular use of beclomethasone did not differ for control of mild asthma. Rees, P. John // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p64 

    The author reflects upon a study investigating whether the symptomatic use of beclomethasone and albuterol in combination, is as effective as regular use of the same dose of beclomethasone, for the asthma patients. He states that the study is a challenge to the importance of regular suppressive...

  • Beclomethasone revisited: the modern view of a classic inhaled corticosteroid. Bakakos, Petros; Loukides, Stelios; Kostikas, Konstantinos // Pneumon;Apr-Jun2014, Vol. 27 Issue 2, p120 

    Asthma is a worldwide problem affecting more than 300 million people of all ages with a relevant impact on quality of life and healthcare resources. International guidelines recommend the combination of a long acting beta-2-agonist and an inhaled corticosteroid when asthma is not fully...

  • Switching patients from other inhaled corticosteroid devices to the Easyhaler: historical, matched-cohort study of real-life asthma patients. Price, David; Thomas, Vicky; von Ziegenweidt, Julie; Gould, Shuna; Hutton, Catherine; King, Christine // Journal of Asthma & Allergy;4/10/2014, Vol. 7, p31 

    No abstract available.

  • Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma. Papi, Alberto; Canonica, Giorgio W.; Maestrelli, Piero; Paggiaro, Pierluigi; Olivieri, Dario; Pozzi, Ernesto; Crimi, Nunzio; Vignola, Antonio M.; Morelli, Paolo; Nicolini, Gabriele; Fabbri, Leonardo M. // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2040 

    Background: Treatment guidelines recommend the regular use of inhaled corticosteroids for patients with mild persistent asthma. We investigated whether the symptom-driven use of a combination of beclomethasone dipropionate and albuterol (also known as salbutamol) in a single inhaler would be as...

  • Steroid-Dependent Asthma Treated with Inhaled Beclomethasone Dipropionate. Davies, G.; Thomas, P.; Broder, I.; Mintz, S.; Silverman, F.; Leznoff, A.; Trotman, C. // Annals of Internal Medicine;May77, Vol. 86 Issue 5, p549 

    Focuses on a study which evaluated the efficacy of inhaled beclomethasone dipropionate in treating steroid-dependent asthmatics. Information on the study population; Administration of beclomethasone to the patients; Adverse effects of treatment with beclomethasone.

  • Comparison of Physician-, Biomarker-r and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma. Calhoun, William J.; Ameredes, Bill T.; King, Tonya S.; Icitovic, Nikolina; Bleecker, Eugene R.; Castro, Mario; Cherniack, Reuben M.; Chinchilli, Vernon M.; Craig, Timothy; Denlinger, Loren; DiMango, Emily A.; Engle, Linda L.; Fahy, John V.; Grant, J. Andrew; Israel, Elliot; Jarjour, Nizar; Kazani, Shamsah D.; Kraft, Monica; Kunselman, Susan J.; Lazarus, Stephen C. // JAMA: Journal of the American Medical Association;9/12/2012, Vol. 308 Issue 10, p987 

    The article presents a randomized clinical trial, Best Adjustment Strategy for Asthma in the Long Term (BASALT) to determine the adjustments of inhaled corticosteroid therapy in preventing treatment failure in adults with mild to moderate asthma. The study concluded that the adults with mild to...


Read the Article


Sign out of this library

Other Topics